524 related articles for article (PubMed ID: 28972170)
1. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
2. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
[TBL] [Abstract][Full Text] [Related]
3. The Hippo pathway member Nf2 is required for inner cell mass specification.
Cockburn K; Biechele S; Garner J; Rossant J
Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
[TBL] [Abstract][Full Text] [Related]
4. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
[TBL] [Abstract][Full Text] [Related]
5. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
[TBL] [Abstract][Full Text] [Related]
6. The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation.
Aslan JE; Baker SM; Loren CP; Haley KM; Itakura A; Pang J; Greenberg DL; David LL; Manser E; Chernoff J; McCarty OJ
Am J Physiol Cell Physiol; 2013 Sep; 305(5):C519-28. PubMed ID: 23784547
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
[TBL] [Abstract][Full Text] [Related]
8. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.
Kissil JL; Wilker EW; Johnson KC; Eckman MS; Yaffe MB; Jacks T
Mol Cell; 2003 Oct; 12(4):841-9. PubMed ID: 14580336
[TBL] [Abstract][Full Text] [Related]
9. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
Hikasa H; Sekido Y; Suzuki A
Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
[TBL] [Abstract][Full Text] [Related]
10. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
11. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
[TBL] [Abstract][Full Text] [Related]
12. Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney disease
Patel S; Tang J; Overstreet JM; Anorga S; Lian F; Arnouk A; Goldschmeding R; Higgins PJ; Samarakoon R
FASEB J; 2019 Sep; 33(9):9797-9810. PubMed ID: 31095421
[TBL] [Abstract][Full Text] [Related]
13. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
[TBL] [Abstract][Full Text] [Related]
14. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38813860
[TBL] [Abstract][Full Text] [Related]
15. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
16. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
[TBL] [Abstract][Full Text] [Related]
17. A critical role for NF2 and the Hippo pathway in branching morphogenesis.
Reginensi A; Enderle L; Gregorieff A; Johnson RL; Wrana JL; McNeill H
Nat Commun; 2016 Aug; 7():12309. PubMed ID: 27480037
[TBL] [Abstract][Full Text] [Related]
18. Viral small T oncoproteins transform cells by alleviating hippo-pathway-mediated inhibition of the YAP proto-oncogene.
Nguyen HT; Hong X; Tan S; Chen Q; Chan L; Fivaz M; Cohen SM; Voorhoeve PM
Cell Rep; 2014 Aug; 8(3):707-13. PubMed ID: 25088426
[TBL] [Abstract][Full Text] [Related]
19. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.
Lavado A; He Y; Paré J; Neale G; Olson EN; Giovannini M; Cao X
Development; 2013 Aug; 140(16):3323-34. PubMed ID: 23863479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
